cimadronate has been researched along with Malignant Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiraga, T; Kitagawa, Y; Yoneda, T; Yura, Y | 1 |
| Hiraga, T; Nakajima, T; Ozawa, H; Tanaka, S; Yamamoto, M | 1 |
2 other study(ies) available for cimadronate and Malignant Melanoma
| Article | Year |
|---|---|
Suppression by incadronate of invasion and growth of A-375 human melanoma in mandible in nude mice.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Resorption; Diphosphonates; Humans; Male; Mandibular Neoplasms; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous; Tumor Cells, Cultured | 2005 |
Inhibitory effects of bisphosphonate (YM175) on bone resorption induced by a metastatic bone tumor.
Topics: Acid Phosphatase; Animals; Biomarkers, Tumor; Bone Neoplasms; Bone Resorption; Diphosphonates; Humans; Immunohistochemistry; Isoenzymes; Male; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Tartrate-Resistant Acid Phosphatase; Tumor Cells, Cultured | 1996 |